Genetics can influence an individual's susceptibility to both cancer and the toxic effects of cancer treatments. Genetic variations can affect how a person metabolizes drugs, leading to differences in treatment efficacy and toxicity. Pharmacogenomics, a field at the intersection of genetics and toxicology, studies these variations to personalize cancer treatment plans, aiming to improve therapeutic outcomes and reduce adverse effects.
